Diabetes Therapy to Improve BMI and Lung Function in CF

NCT00072904 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

108

Enrollment

NIH

Sponsor class

Conditions

Cystic Fibrosis
Diabetes Mellitus

Interventions

DRUG: Insulin Asparte
DRUG: Repaglinide

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]